Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Switzerland; Bürgerspital Solothurn, Department of Surgery, Solothurn, Switzerland.
Basel Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University Hospital Basel and University of Basel, Switzerland.
Eur J Surg Oncol. 2021 Jun;47(6):1324-1331. doi: 10.1016/j.ejso.2021.04.006. Epub 2021 Apr 16.
In 2013 Swiss health authorities implemented annual hospital caseload requirements (CR) for five areas of visceral surgery. We assess the impact of the implementation of CR on indication for surgery in esophageal, pancreatic and rectal cancer.
Retrospective analysis of national registry data of all inpatient admissions between January 1st 2005 and December 31st 2015. Primary end-point was the age-adjusted resection rate for esophageal, pancreatic and rectal cancer among patients with at least one cancer-specific hospitalization per year. We calculated age-adjusted rate ratios for period effects before and after implementation of CR and odds ratios (OR) based on a generalized estimation equation. A relative increase of 5% in age-adjusted relative risk was set a priori as relevant from a health policy perspective.
Age-adjusted resection rates before and after the implementation of CR were 0.12 and 0.13 (Relative Risk [RR] 1.08; 95%-Confidence Interval [CI] 0.85-1.36) in esophageal cancer, 0.22 and 0.26 (RR 1.17; 95%-CI 0.85-1.58) in pancreatic cancer and 0.38 and 0.43 (RR 1.14; 95%-CI 0.99-1.30) in rectal cancer. In adjusted models OR for resection after the implementation of CR were 1.40 (95%-CI 1.24-1.58) in esophageal cancer, 1.05 (95%-CI 0.96-1.15) in pancreatic cancer and 0.92 (95%-CI 0.87-0.97) in rectal cancer.
Implementation of CR was associated with an increase of resection rates above the a priori set margins in all resections groups. In adjusted models, odds for resection were significantly higher for esophageal cancer, while they remained unchanged for pancreatic and decreased for rectal cancer.
2013 年,瑞士卫生当局对内脏外科的五个领域实施了年度医院病例量要求(CR)。我们评估了实施 CR 对食管、胰腺和直肠癌症手术指征的影响。
对 2005 年 1 月 1 日至 2015 年 12 月 31 日期间所有住院患者的国家登记数据进行回顾性分析。主要终点是每年至少有一次癌症特定住院治疗的患者中食管、胰腺和直肠癌症的年龄调整切除率。我们计算了 CR 实施前后时期效果的年龄调整率比值和基于广义估计方程的比值比(OR)。从卫生政策角度出发,预先设定了 5%的年龄调整相对风险增加作为相关标准。
CR 实施前后的年龄调整切除率分别为 0.12 和 0.13(相对风险 [RR] 1.08;95%-置信区间 [CI] 0.85-1.36)在食管癌中,0.22 和 0.26(RR 1.17;95%-CI 0.85-1.58)在胰腺癌中,0.38 和 0.43(RR 1.14;95%-CI 0.99-1.30)在直肠癌中。在调整后的模型中,CR 实施后的切除 OR 分别为 1.40(95%-CI 1.24-1.58)在食管癌中,1.05(95%-CI 0.96-1.15)在胰腺癌中,0.92(95%-CI 0.87-0.97)在直肠癌中。
CR 的实施与所有切除术组中超过预先设定幅度的切除率增加有关。在调整后的模型中,食管癌切除的几率显著更高,而胰腺癌则保持不变,直肠癌则降低。